Journal article icon

Journal article

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

Abstract:

BACKGROUND: A serogroup B meningococcal vaccine (4CMenB) has been licensed by the European commission for use in various infant schedules. However, data are limited on persistence of serum bactericidal antibodies (SBA), which is necessary to inform cost-effectiveness analysis. METHODS: Sera were obtained from 3 groups of 5-year-old children previously immunized at 6, 8, 12 and 40 months with either 4CMenB or rMenB (which lacks the outer membrane vesicle of 4CMenB) or at 40 and 42 months with ...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Publisher:
Lippincott Williams and Wilkins
Journal:
Pediatric infectious disease journal
Volume:
33
Issue:
7
Pages:
760-766
Publication date:
2014-07-01
DOI:
EISSN:
1532-0987
ISSN:
0891-3668
Source identifiers:
462117
Language:
English
Keywords:
Pubs id:
pubs:462117
UUID:
uuid:3645be35-8d30-4c2d-8abd-af4d24515181
Local pid:
pubs:462117
Deposit date:
2014-05-12

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP